Montesco Chewing Tablet 4 mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Tablet · Prescription medication
Os-Korea Pharmaceutical Co., Ltd.
MFDS item code 201501928 · Approved 2015.04.09
This product's status changed to Expired on 2025.04.09. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Prevention and ongoing treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
This medication is used to prevent and continuously treat asthma. It is also effective in relieving symptoms of seasonal and perennial allergic rhinitis. Thus, it helps to reduce discomfort caused by asthma and allergic rhinitis, and to manage symptoms.
Take this drug once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, determine the dosing time according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily. Adults and adolescents aged 15 years and older: Place 10 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. To take, pour the contents of 1 sachet into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use; after opening, immediately (within 15 minutes) suspend it in water and take the entire amount. Do not leave this drug suspended in water for a prolonged period. The 4 mg granules may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food, such as room-temperature or cooler infant food, breast milk, or porridge. Do not open the package until immediately before use; after opening, immediately (within 15 minutes) mix it with infant food, breast milk, or food, or take the entire amount as is. Do not leave this drug mixed with infant food, breast milk, or food for a prolonged period; discard any remainder. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be taken immediately after administration. This drug may be taken regardless of meal times.
Children aged 6~14 years: Chew and take 5 mg of montelukast once daily. Take this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Chew and take 4 mg of montelukast once daily. Take this drug 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and, after it disintegrates, take without water. Take this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and, after it disintegrates, take without water. Take this drug 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. Take this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. Take this drug 1 hour before or 2 hours after a meal. Children aged 6~14 years: Administer 5mg of montelukast orally once daily. Take this drug 1 hour before or 2 hours after a meal. Asthma Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Infants aged 12 months~under 2 years: Administer 4 mg of this drug orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. Allergic rhinitis Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants aged 6 months~under 2 years: Administer 4mg of this drug orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age.
This medication contains the artificial sweetener aspartame, which is broken down into phenylalanine in the body. Thus, patients with the hereditary disease phenylketonuria should not take this medication. This medication contains lactose, so it should not be administered to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. This medication is primarily used for patients with asthma and allergic rhinitis, and its safety and efficacy have been confirmed in clinical trials across various age groups. However, some patients may experience a variety of adverse reactions such as weakness, fatigue, headache, dyspepsia, rash, cough, and others, so they should consult a physician if symptoms occur. This medication is not intended for use during acute asthma attacks, and an emergency inhaler should always be ready during asthma exacerbations. During treatment, neuropsychiatric symptoms such as anxiety, depression, hallucinations, and behavior changes may occur, so any changes should be reported to healthcare providers immediately. If there is a history of hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs, they should be avoided while taking this medication. During the course of treatment, the dosage of inhaled corticosteroids should be adjusted according to doctor's instructions, as abrupt withdrawal or changes may be dangerous. During pregnancy or breastfeeding, due to insufficient data on the safety of this medication, it should be administered only after consulting a physician. Children and elderly patients can also use this medication, but particular attention should be paid to the age and dosage in children, and safety has not been established for children under 6 months of age. There is no specific antidote for overdose, so if overdose is suspected, appropriate treatment should be sought at a medical facility immediately. This medication is sensitive to light, so it should be opened just before use, and taken immediately after opening. Store this medication out of reach of children and do not transfer it to another container. Lastly, this medication should be taken consistently even during periods without asthma symptoms, and any worsening of symptoms or emergence of new symptoms should be discussed with a physician.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Also, it should be kept away from direct sunlight, ideally at a temperature between 1 and 30 degrees Celsius.
Pink, oval-shaped chewable tablet with a convex surface on both sides
28T (7T/PTP packaging x4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 4.16mg
Tablet · Prescription medication
Os-Korea Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.